Evidence map›Paper›PMID 38260834›Full record

ArticleFrontiers in oncology2023

Case report: Benign and malignant tumors in adult patients with neurofibromatosis type 1: a comprehensive case series from a large oncologic reference center.

Silvia Vidal-Millan, Zyanya Lucia Zatarain-Barrón, Kena Daza-Galicia, Daniela Shveid Gerson, Pavel Salvador Pichardo-Rojas, Alejandro Salazar-Pigeon, Talia Wegman-Ostrosky

Open access · goldAbstract readCase Reports
In one paragraph

Article in Frontiers in oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Silvia Vidal-MillanHereditary Cancer Clinic, Instituto Nacional de Cancerologia, Mexico City, Mexico.
Zyanya Lucia Zatarain-BarrónDepartment of Math and Science, Arkansas State University Querétaro, Querétaro, Mexico.
Kena Daza-GaliciaSubdirection of Basic Research, Instituto Nacional de Cancerología, Mexico City, Mexico.
Daniela Shveid GersonOncology Department, ABC Medical Center, Mexico City, Mexico.
Pavel Salvador Pichardo-RojasThe Vivian L. Smith Department of Neurosurgery, The University of Texas Health Science Center at Houston McGovern Medical School, Houston, TX, United States.
Alejandro Salazar-PigeonPlan of Combined Studies in Medicine (PECEM-MD/PhD), Faculty of Medicine, Universidad Nacional Autónoma de México, Mexico City, Mexico.
Talia Wegman-OstroskySubdirection of Basic Research, Instituto Nacional de Cancerología, Mexico City, Mexico.
Instituto Nacional de Cancerología · MXUniversidad Nacional Autónoma de México · MXCentro Médico ABC · MXThe University of Texas Health Science Center at Houston · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Neurofibromatosis type 1 (NF1) is a complex, multisystem disorder that is characterized, among other features, by a higher risk of developing benign and malignant tumors. Despite NF1 being one of the most common autosomal dominant genetic disorders, data from adult individuals in several world regions remain elusive, including Hispanics. Methods: The present is a retrospective cohort study conducted among adult patients with a confirmed diagnosis of NF1 who attended a single cancer-reference center, the Instituto Nacional de Cancerología in Mexico City from 2001 to 2021. Data were extracted from electronic health records and collected in an anonymous database by an NF1-expert physician in order to obtain demographic characteristics and detailed information regarding the development of tumors among this patient subgroup. All patients with malignant tumors or with benign tumors, which severely affected their quality of life, were included in this study. Results: Patient records were reviewed from 2001 to 2021. A total of Conclusion: In Mexico, patients diagnosed with NF1 develop diverse tumors as adults. As described in other studies, the most frequent malignant tumor in this patient population is the malignant peripheral nerve sheath tumor. Further studies are required to increase the scarce information available for adult Hispanics with NF1.

Indexed as

adultsbreast cancerHispanicsmalignanciesmalignant peripheral nerve sheath tumorsneurofibromatosis type 1

Identifiers

PMID38260834
PMCPMC10800395
OpenAlexW4390665608

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.